SWTX — SpringWorks Therapeutics Share News
0.000.00%
Last trade - 00:00- $3.54bn
- $3.25bn
- $191.59m
Germany's Merck nears roughly $3.5 billion deal for SpringWorks, WSJ reports (updated)
SpringWorks rises after report Germany's Merck has made nearly $3.5 billion deal
Germany's Merck nears roughly $3.5 billion deal for SpringWorks, WSJ reports
Brief: Merck KGaA CEO: Impact From U.S. Tariffs On China Will Be Manageable
U.S. STOCKS ON THE MOVE-Repligen, Mangoceuticals, Insmed
U.S. STOCKS ON THE MOVE-Sabre, MicroStrategy, Repligen
SpringWorks Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
U.S. STOCKS ON THE MOVE-Roku, BioMarin, Assurant
SpringWorks Therapeutics rises as canceled earnings call raises buyout hopes
Deals of the day-Mergers and acquisitions
Brief: Springworks Therapeutics Announces FDA Approval Of Gomekli (Mirdametinib) For Treatment Of Adult And Pediatric Patients With NF1-PN
US FDA approves SpringWorks' genetic disorder drug (updated)
Brief: FDA Approved Mirdametinib, For Adult & Pediatric Patients 2 Years Of Age & Older With Nf1 Who Have Symptomatic Pn Not Amenable To Complete Resection
US FDA approves Springworks' genetic disorder drug
Germany's Merck in advanced talks to acquire US biotech firm SpringWorks (updated)
Germany's Merck in advanced talks to acquire US biotech firm Springworks
U.S. STOCKS ON THE MOVE-Nike, WesBanco, Monday.Com
Springworks jumps after Reuters reports Merck KGaA in talks to buy company
Germany's Merck KGaA in talks to buy US biotech firm Springworks, sources say